Q3 FY26 saw revenue rise 23.3% year-over-year to $5,977k, with underlying NPATA up 22.1% to $979k. ARC-related business drove growth, while general practice enrolments declined. A fully imputed 4.00 cent dividend was declared.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.